NIH-funded research R01 grant

Boosting surface brain vessel blood flow during large strokes

Official title: Targeting Pial Collaterals for Acute Stroke Treatment

Funded at University of Vermont & St Agric College · NIH-11057594 · Data updated 2026-11-12

This project tests treatments to keep tiny surface brain vessels open during a major ischemic stroke to help people—especially those with chronic high blood pressure—save more brain tissue.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Vermont & St Agric College
NIH-funded
Lab location1 site (Burlington, United States)
Project startJune 1, 2015
Project endNovember 30, 2026
Funding year2026
Award (this year)$444,945
NIH project number5R01NS093289-10
Project IDNIH-11057594 on NIH RePORTER

Who could benefit from this research

Could help

People who have had or are at high risk for acute large-vessel ischemic stroke—particularly those with chronic high blood pressure—would be the most relevant candidates for related trials.

Less likely to help

People with bleeding (hemorrhagic) stroke, small-vessel stroke types, or conditions unrelated to large-vessel ischemia are unlikely to benefit from these specific approaches.

What this research studies

You would hear that researchers are focused on the pial collaterals, small surface brain vessels that can keep blood flowing to threatened brain tissue during a large-vessel stroke. In lab studies they compare vessels from animals with normal blood pressure and with chronic hypertension to see why high blood pressure causes these vessels to constrict and fail. The team studies molecules such as angiotensin II and PAI-1 that drive vessel tightening and tests ways to prevent that constriction so the penumbra gets more blood. The long-term aim is to develop treatments that could be used during or soon after a large-vessel stroke to preserve brain tissue and improve recovery.

Why it matters

Potential benefit: If successful, this work could lead to treatments that preserve more brain tissue during large-vessel strokes and improve recovery, especially for people with chronic hypertension.

How similar studies have gone: Prior animal studies, including this team's published work, suggest that targeting angiotensin II–related vessel constriction can improve collateral flow, but successful translation to people remains unproven.

Where this research is happening

  • University of Vermont & St Agric College
    Burlington, United States
    Active

Researchers

  • Principal investigator: Cipolla, Marilyn J — University of Vermont & St Agric College
  • Study coordinator: Cipolla, Marilyn J

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.